Filing Details
- Accession Number:
- 0001209191-22-062664
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-23 18:33:47
- Reporting Period:
- 2022-12-22
- Accepted Time:
- 2022-12-23 18:33:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1851194 | Ventyx Biosciences Inc. | VTYX | Pharmaceutical Preparations (2834) | 832996852 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874108 | John Nuss | C/O Ventyx Biosciences, Inc. Encinitas Blvd, Suite 250 Encinitas CA | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-12-22 | 13,812 | $31.61 | 244,815 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
- Represents the weighted average share price of an aggregate total of 13,812 shares sold in the price range of $31.60 to $32.095. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
